CD8A and COVID-19: To investigate the role of galectin-3 in the impaired mitochondrial biogenesis of CD8+ T cells in COVID-19 patients, TD-139, a high-affinity inhibitor of galectin-3, was utilized in the A549-3a/CD8+ T cell co-culture system.